Medine.co.uk

Emulsifying Ointment Bp

Informations for option: Emulsifying Ointment Bp, show other option
Document: spc-doc_PL 28444-0134 change

SUMMARY OF PRODUCT CHARACTERISTICS

1    NAME OF THE MEDICINAL PRODUCT

Emulsifying Ointment BP

2    QUALITATIVE AND QUANTITATIVE COMPOSITION

White Soft Paraffin BP 50.0% w/w Emulsifying Wax BP 30.0% w/w Liquid Paraffin BP 20.0% w/w

3 PHARMACEUTICAL FORM

Ointment

4    CLINICAL PARTICULARS

4.1    Therapeutic indications

As an emollient in the management of dry skin including chronic eczema, as a soap substitute and as a vehicle for medications.

4.2 Posology and method of administration

For External use only

Adults (including the elderly) and Children

Apply to the affected area 1 to 3 times daily until an improvement occurs

4.3 Contraindications

Hypersensitivity to any of the ingredients.

4.4 Special warnings and precautions for use

For External use only Store below 25 °C Keep well closed.

4.5    Interaction with other medicinal products and other forms of interaction

None known

4.6    Fertility, Pregnancy and lactation

There is no evidence of hazard to suggest that this product should not be used in pregnancy and lactation.

4.7    Effects on ability to drive and use machines

None.

4.8    Undesirable effects

Very rarely hypersensitivity reactions may occur.

4.9    Overdose

If accidentally ingested, nausea, vomiting and diarrhoea may occur. Treatment should be symptomatic.

5 PHARMACOLOGICAL PROPERTIES

5.1 Pharmacodynamic properties

The ingredients have an emollient effect. They soothe and hydrate the skin by acting as a barrier.

5.2 Pharmacokinetic properties

Liquid paraffin is absorbed to a slight extent. Soft Paraffin and Emulsifying Wax are not readily absorbed. They have no systemic effect.

5.3 Preclinical safety data

None stated

PHARMACEUTICAL PARTICULARS

6


6.1    List of excipients

None

6.2    Incompatibilities

None stated

6.3 Shelf life

3 Years

6.4 Special precautions for storage

Store below 25° C Keep well closed.

6.5    Nature and contents of container

Plastic containers and lids    500g

6.6    Special precautions for disposal

None Stated

7    MARKETING AUTHORISATION HOLDER

Activase Pharmaceuticals Limited,

11 Boumpoulinas,

PC. 1060 Nicosia.

Cyprus

8    MARKETING AUTHORISATION NUMBER(S)

PL 28444/0134

9    DATE OF FIRST AUTHORISATION/RENEWAL OF THE

AUTHORISATION

13/03/2013

10 DATE OF REVISION OF THE TEXT

11/10/2013